A Structural Core Within Apolipoprotein C-II Amyloid Fibrils Identified Using Hydrogen Exchange and Proteolysis

https://doi.org/10.1016/j.jmb.2006.12.040Get rights and content

Abstract

Plasma apolipoproteins show α-helical structure in the lipid-bound state and limited conformational stability in the absence of lipid. This structural instability of lipid-free apolipoproteins may account for the high propensity of apolipoproteins to aggregate and accumulate in disease-related amyloid deposits. Here, we explore the properties of amyloid fibrils formed by apolipoproteins using human apolipoprotein (apo) C-II as a model system. Hydrogen-deuterium exchange and NMR spectroscopy of apoC-II fibrils revealed core regions between residues 19–37 and 57–74 with reduced amide proton exchange rates compared to monomeric apoC-II. The C-terminal core region was also identified by partial proteolysis of apoC-II amyloid fibrils using endoproteinase GluC and proteinase K. Complete tryptic hydrolysis of apoC-II fibrils followed by centrifugation yielded a single peptide in the pellet fraction identified using mass spectrometry as apoC-II56-76. Synthetic apoC-II56-76 readily formed fibrils, albeit with a different morphology and thioflavinT fluorescence yield compared to full-length apoC-II. Studies with smaller peptides narrowed this fibril-forming core to a region within residues 60–70. We postulate that the ability of apoC-II60-70 to independently form amyloid fibrils drives fibril formation by apoC-II. These specific amyloid-forming regions within apolipoproteins may underlie the propensity of apolipoproteins and their peptide derivatives to accumulate in amyloid deposits in vivo.

Introduction

Current interest in the structure and assembly mechanisms for amyloid fibrils stems from their association with a wide range of debilitating diseases. In addition, amyloid fibrils are an alternative stable structural fold, the study of which could yield valuable insight into the fundamental rules of protein folding.1 In this vein, over two decades of structural studies on amyloid fibrils have painted an informative, if low-resolution, picture of the common features and supramolecular organization of the amyloid fibril, detailing a cross-β core consisting of tightly packed, self-complementing β sheets.2., 3., 4. At the molecular level however, it is clear that amyloid fibrils formed by different proteins differ structurally in a number of ways, including the extent to which cross-β structure is formed along their sequences, strand orientation and the organization of the core amyloid structure within the protein.5., 6., 7., 8. These differences are likely to have significant effects on both the solution and functional properties of amyloid fibrils and could substantially impact on their in vivo processing and manifestation during different disease states. In the absence of a complete understanding of the general formation of amyloid structure, local structural information on protein and disease-specific amyloid fibrils remains critical.

Of the set of proteins that form amyloid fibrils in vivo, plasma apolipoproteins are over-represented. For instance, apolipoprotein (apo)1 A-I mutants are associated with several hepatic and systemic amyloid disorders,9., 10. while apoA-II forms amyloid fibrils with a renal localization.11 Serum amyloid A, an acute phase reactant of the apolipoprotein family, self-aggregates to form amyloid fibrils at various sites of inflammation.12 A C-terminal fragment of apoE binds Aβ fibrils in neuritic plaques and itself forms amyloid fibrils in vitro.13 In addition, we have recently demonstrated that apoB in low-density lipoproteins (LDL) acquires amyloid-like structures under oxidizing conditions. Oxidation of LDL promotes their uptake by macrophages in a step that precedes foam cell formation and atherosclerosis.14 Furthermore, immunohistochemical studies of atherosclerotic plaques reveal the presence of apoA-I, apoB, apoC-II and apoE aggregates.15., 16. The aberrant deposition of these amyloid species in the artery wall may contribute to decreased elasticity of blood vessels, the induction of vascular inflammation, and alterations in lipid metabolism.17

Sequence comparisons of apolipoprotein genes indicate a multigene family with a common ancestry.18 A common property of the apolipoprotein family is the high proportion of class-A amphipathic helices implicated in lipid binding,19 and a limited conformational stability in the absence of lipid that is postulated to underlie their propensity to form amyloid.20 In addition, proteases that are abundant in atherosclerotic lesions, cathepsins B, K, and L, cleave apolipoprotein A-I to generate intermediate-sized fragments that form amyloid.21 All of these parameters may contribute to the accumulation of apolipoprotein-derived amyloid in atherosclerotic lesions. However, despite their apparent prevalence in amyloid deposits, little is known about the mechanisms of amyloid formation by apolipoproteins or their detailed structure in the amyloid state.

Human apoC-II is a 79-residue component of very-low-density lipoproteins, where it plays an essential role in activating lipoprotein lipase during lipid metabolism. ApoC-II readily aggregates under lipid-poor conditions to form homogeneous fibrils22 and is one of the few amyloid systems to form fibrils at physiological pH without prolonged agitation. Plasma apoC-II accumulates in atherosclerotic plaques,23 where it co-localizes with serum amyloid P component, a non-fibrillar marker of amyloid deposits.16 While this co-localization provides a prima facie case for the presence of apoC-II fibrils in vivo, definitive evidence requires the development of specific reagents that can distinguish fibrillar and non-fibrillar forms of this protein. The amyloidogenic properties of apoC-II have been extensively studied in vitro and these studies form the basis for much of the current knowledge of amyloid fibril formation by the apolipoproteins.17 ApoC-II fibrils initiate macrophage inflammatory responses via the CD36 receptor, including reactive oxygen production and TNF-α expression, which promote atherogenesis.16 Here, we study apoC-II as a model system for amyloid fibrils formed by the apolipoproteins. Using a combined approach of hydrogen/deuterium (H/D) exchange and proteolysis experiments we sought to identify the core region(s) within apoC-II fibrils that predispose to amyloid formation.

Section snippets

NMR analysis of apoC-II fibrils

Initial NMR experiments to assign the NH resonances of dimethylsulfoxide (DMSO) denatured monomeric apo-CII were performed. Samples of [13C,15N]apoC-II were prepared by solubilizing apoC-II fibrils into monomers in 95% (v/v) d6-DMSO, 4.5% H2O, 0.5% d2-DCA. Standard triple resonance experiments were recorded and near complete sequential resonance assignment of [13C,15N]apoC-II was achieved (Figure 1(a)). Measurements of H/D exchange of fibrillar 15N-labeled apoC-II were then performed to probe

Discussion

Our hydrogen/deuterium exchange experiments with apoC-II amyloid fibrils have revealed two core regions protected from exchange, residues 19–37 and 57–74. Our results can be compared with those previously obtained for other amyloid-forming proteins. The Aβ1-40 peptide forms fibrils with a core region in the C-terminal half of the peptide,6 while the Het-s prion domain possesses a series of short, protected regions between two to eight residues in length alternating with more accessible regions.8

Materials

ApoC-II was expressed and purified as described22 and stored as a concentrated stock solution in 5 M guanidine hydrochloride, 10 mM Tris-HCl (pH 8) at −20 °C. ApoC-II amyloid fibrils were prepared by dilution of the stock solution in buffer (100 mM sodium phosphate (pH 7.4), 0.1% (w/v) sodium azide) to a final concentration of 0.4 mg/ml and incubated at room temperature for five days. 15N and 13C enrichment of apoC-II was performed as described by Marley and co-authors.41

Hydrogen/deuterium exchange and NMR spectroscopy

Labeled apoC-II amyloid

Acknowledgements

We thank Chi L. L. Pham and Lynne Waddington for assistance with electron microscopy and Ben Atcliffe for advice on HPLC experiments. This work was supported by a grant from the Australian Research Council (grant number DP0449510).

References (48)

  • R. Azriel et al.

    Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation

    J. Biol. Chem.

    (2001)
  • A. Kapurniotu et al.

    Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity

    J. Mol. Biol.

    (2002)
  • A. Andreola et al.

    Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I

    J. Biol. Chem.

    (2003)
  • A.M. Scanu et al.

    Proteolytic events affecting plasma apolipoproteins at the co- and post-translational levels and after maturation

    J. Lipid Res.

    (1984)
  • R. Fluhrer et al.

    Identification of a beta-secretase activity, which truncates amyloid beta-peptide after its presenilin-dependent generation

    J. Biol. Chem.

    (2003)
  • Y.F. Mok et al.

    Sedimentation velocity analysis of amyloid oliomers and fibrils

    Methods Enzymol.

    (2006)
  • H. Schagger et al.

    Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

    Anal. Biochem.

    (1987)
  • R. Nelson et al.

    Structure of the cross-beta spine of amyloid-like fibrils

    Nature

    (2005)
  • C. Ritter et al.

    Correlation of structural elements and infectivity of the HET-s prion

    Nature

    (2005)
  • J.C. Chan et al.

    Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10-39 of the yeast prion protein Ure2p

    Biochemistry

    (2005)
  • C. Del Mar et al.

    Structure and properties of alpha-synuclein and other amyloids determined at the amino acid level

    Proc. Natl Acad. Sci. USA

    (2005)
  • N.A. Whittemore et al.

    Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy

    Biochemistry

    (2005)
  • M. Hoshino et al.

    Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange

    Nature Struct. Biol.

    (2002)
  • H.Y. Rienhoff et al.

    Molecular and cellular biology of serum amyloid A

    Mol. Biol. Med.

    (1990)
  • Cited by (54)

    • Amyloid fibril formation by α<inf>S1</inf>- and β-casein implies that fibril formation is a general property of casein proteins

      2022, Biochimica et Biophysica Acta - Proteins and Proteomics
      Citation Excerpt :

      Thus, camel β-casein showed a greater propensity to aggregate and form amyloid fibrils than its cow and goat counterparts. Native and fibrillar forms of camel and cow β-casein were partially digested with trypsin to determine the regions of these proteins that are incorporated into the β-sheet fibril core, since such regions are relatively protease resistant [66]. The trypsin-digested products were analysed by SDS-PAGE and a protease-resistant fragment was identified by comparison of protease digestion of the fibrillar with the native forms (Fig. 6A).

    • Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease

      2021, Journal of Lipid Research
      Citation Excerpt :

      However, the biological route remains obscure, and whether increased proteolysis of related apolipoproteins is necessarily involved remains unclear. In a previous study, which demonstrated that some of the lipid-free apoC-II's amino acid sequences are protected from proteolytic cleavage, it was proposed that certain morphologies can promote amyloid formation: monomeric lipid-free apoC-II's regions that were less protected from H/D exchange and proteolysis corresponded to the core within its amyloid fibrils (42). Interestingly, apoC-II, apoA-I, and apoB aggregates were also found in atherosclerotic plaques (69), and apoA-I, apoA-II, apoC-I, apoB100, and apoE were found to colocalize with amyloid in vivo (39, 70, 71), although they were not necessarily truncated.

    View all citing articles on Scopus

    L.M.W. and Y.-F.M. contributed equally to this work.

    View full text